Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study

ConclusionsOur data suggests that RDV is safe in children, with no reported serious AEs. However, the absence of a control group limits the extent to which conclusions can be drawn. RDV may contribute to clinical improvement, particularly in high-risk patients.
Source: Molecular and Cellular Pediatrics - Category: Cytology Source Type: research